| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. | J Antimicrob Chemother | 2010 | 2.41 |
| 2 | Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection. | J Pharm Biomed Anal | 2011 | 2.10 |
| 3 | Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. | AIDS Res Hum Retroviruses | 2012 | 1.89 |
| 4 | Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone. | Br J Clin Pharmacol | 2013 | 0.90 |
| 5 | Zidovudine and Lamivudine for HIV Infection. | Clin Med Rev Ther | 2010 | 0.89 |
| 6 | A population pharmacokinetic-pharmacogenetic analysis of atazanavir. | AIDS Res Hum Retroviruses | 2012 | 0.86 |